MEDICO REMEDIES Financial Statement Analysis
|
||
|
The Revenues of MEDICO REMEDIES have increased by 16.04% YoY .
The Earnings Per Share (EPS) of MEDICO REMEDIES has decreased by -70.00 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
MEDICO REMEDIES Last 5 Annual Financial Results
[BOM: 540937|NSE : MEDICO]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹140 Cr | ₹121 Cr | ₹122 Cr | ₹89 Cr | ₹98 Cr |
| Expenses | ₹131 Cr | ₹114 Cr | ₹117 Cr | ₹86 Cr | ₹95 Cr |
| Operating Profit (Excl OI) | ₹9.48 Cr | ₹7.34 Cr | ₹5.24 Cr | ₹2.84 Cr | ₹2.76 Cr |
| Other Income | ₹4.09 Cr | ₹2.03 Cr | ₹1.03 Cr | ₹2.10 Cr | ₹1.90 Cr |
| Interest | ₹0.75 Cr | ₹0.66 Cr | ₹0.92 Cr | ₹1.06 Cr | ₹0.98 Cr |
| Depreciation | ₹2.72 Cr | ₹2.22 Cr | ₹1.65 Cr | ₹1.66 Cr | ₹1.51 Cr |
| Profit Before Tax | ₹10 Cr | ₹6.48 Cr | ₹3.70 Cr | ₹2.22 Cr | ₹2.18 Cr |
| Profit After Tax | ₹7.24 Cr | ₹4.81 Cr | ₹2.59 Cr | ₹1.63 Cr | ₹1.57 Cr |
| Consolidated Net Profit | ₹7.24 Cr | ₹4.81 Cr | ₹2.59 Cr | ₹1.63 Cr | ₹1.57 Cr |
| Earnings Per Share (Rs) | ₹0.87 | ₹2.90 | ₹6.24 | ₹3.93 | ₹3.78 |
| PAT Margin (%) | 5.16 | 3.98 | 2.12 | 1.84 | 1.61 |
| ROE(%) | 18.01 | 13.94 | 8.31 | 5.61 | 5.72 |
| ROCE(%) | 21.88 | 15.09 | 10.13 | 7.66 | 7.79 |
| Total Debt/Equity(x) | 0.18 | 0.29 | 0.46 | 0.46 | 0.48 |
Key Financials |
||
| Market Cap | : | ₹ 362.2 Cr |
| Revenue (TTM) | : | ₹ 131.6 Cr |
| Net Profit(TTM) | : | ₹ 7.0 Cr |
| EPS (TTM) | : | ₹ 0.8 |
| P/E (TTM) | : | 52.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MEDICO REMEDIES | -1.5% | -8.4% | -46% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% | -5.7% | 55.1% |
| CIPLA | 1.1% | -4.4% | 55.5% |
| DR REDDYS LABORATORIES | 0.1% | 1.1% | 28.1% |
| ZYDUS LIFESCIENCES | 6% | 2.8% | 93.1% |
| DIVIS LABORATORIES | -0.7% | 9.4% | 21.4% |
| MANKIND PHARMA | -4.2% | -4.7% | NA |
| TORRENT PHARMACEUTICALS | 1% | 1.8% | 65.1% |
| LUPIN | 2.6% | 4.3% | 133.6% |
MEDICO REMEDIES Revenues
[BOM: 540937|NSE : MEDICO]
| Y-o-Y | 16.04 % |
| 5 Yr CAGR | 9.50 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹140 Cr | 16.04 | |
| Mar2022 | ₹121 Cr | -1.12 | |
| Mar2021 | ₹122 Cr | 38.08 | |
| Mar2020 | ₹89 Cr | -9.27 | |
| Mar2019 | ₹98 Cr | - | |
MEDICO REMEDIES Operating Profit
[BOM: 540937|NSE : MEDICO]
| Y-o-Y | 29.26 % |
| 5 Yr CAGR | 36.10 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹9.48 Cr | 29.26 | |
| Mar2022 | ₹7.34 Cr | 39.98 | |
| Mar2021 | ₹5.24 Cr | 84.44 | |
| Mar2020 | ₹2.84 Cr | 2.82 | |
| Mar2019 | ₹2.76 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 11.39 % |
| 5 Yr CAGR | 24.27 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 6.75% | 11.39 | |
| Mar2022 | 6.06% | 41.59 | |
| Mar2021 | 4.28% | 33.33 | |
| Mar2020 | 3.21% | 13.43 | |
| Mar2019 | 2.83% | - | |
MEDICO REMEDIES Profit After Tax
[BOM: 540937|NSE : MEDICO]
| Y-o-Y | 50.50 % |
| 5 Yr CAGR | 46.55 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹7.24 Cr | 50.50 | |
| Mar2022 | ₹4.81 Cr | 85.79 | |
| Mar2021 | ₹2.59 Cr | 58.90 | |
| Mar2020 | ₹1.63 Cr | 3.82 | |
| Mar2019 | ₹1.57 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 29.65 % |
| 5 Yr CAGR | 33.80 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 5.16 % | 29.65 | |
| Mar2022 | 3.98 % | 87.74 | |
| Mar2021 | 2.12 % | 15.22 | |
| Mar2020 | 1.84 % | 14.29 | |
| Mar2019 | 1.61 % | - | |
MEDICO REMEDIES Earnings Per Share (EPS)
[BOM: 540937|NSE : MEDICO]
| Y-o-Y | -70.00 % |
| 5 Yr CAGR | -30.74 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹0.87 | -70.00 | |
| Mar2022 | ₹2.90 | -53.53 | |
| Mar2021 | ₹6.24 | 58.78 | |
| Mar2020 | ₹3.93 | 3.97 | |
| Mar2019 | ₹3.78 | - | |
MEDICO REMEDIES Return on Capital Employed (ROCE)
[BOM: 540937|NSE : MEDICO]
| Y-o-Y | 45.00 % |
| 5 Yr CAGR | 29.46 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 21.88% | 45.00 | |
| Mar2022 | 15.09% | 48.96 | |
| Mar2021 | 10.13% | 32.25 | |
| Mar2020 | 7.66% | -1.67 | |
| Mar2019 | 7.79% | - | |
MEDICO REMEDIES Share Price vs Sensex
| Current Share Price | : | ₹43.6 |
| Current MarketCap | : | ₹ 362.2 Cr |
| Updated EOD on | : | May 07,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICO REMEDIES | -1.5% |
-8.4% |
-46% |
| SENSEX | -1.6% |
-0.5% |
19.8% |
MEDICO REMEDIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about MEDICO REMEDIES Financials
How the annual revenues of MEDICO REMEDIES have changed ?
The Revenues of MEDICO REMEDIES have increased by 16.04% YoY .
How the Earnings per Share (EPS) of MEDICO REMEDIES have changed?
The Earnings Per Share (EPS) of MEDICO REMEDIES has decreased by -70.00 % YoY .
Check out Intrinsic Value of Peers of MEDICO REMEDIES
Compare Stock Analytics of Peers of MEDICO REMEDIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
